Related Experiment Video
Updated: May 14, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Induced pluripotent stem cells with a mitochondrial DNA deletion
Anne B C Cherry1, Katelyn E Gagne, Erin M McLoughlin
1Boston Children's Hospital, Boston, MA, USA.
Abstract:
In congenital mitochondrial DNA (mtDNA) disorders, a mixture of normal and mutated mtDNA (termed heteroplasmy) exists at varying levels in different tissues, which determines the severity and phenotypic expression of disease. Pearson marrow pancreas syndrome (PS) is a congenital bone marrow failure disorder caused by heteroplasmic deletions in mtDNA. The cause of the hematopoietic failure in PS is unknown, and adequate cellular and animal models are lacking. Induced pluripotent stem (iPS) cells are particularly amenable for studying mtDNA disorders, as cytoplasmic genetic material is retained during direct reprogramming. Here, we derive and characterize iPS cells from a patient with PS. Taking advantage of the tendency for heteroplasmy to change with cell passage, we isolated isogenic PS-iPS cells without detectable levels of deleted mtDNA. We found that PS-iPS cells carrying a high burden of deleted mtDNA displayed differences in growth, mitochondrial function, and hematopoietic phenotype when differentiated in vitro, compared to isogenic iPS cells without deleted mtDNA. Our results demonstrate that reprogramming somatic cells from patients with mtDNA disorders can yield pluripotent stem cells with varying burdens of heteroplasmy that might be useful in the study and treatment of mitochondrial diseases.
Insights
Mitochondrial DNA disorders involve heteroplasmy, a mix of normal and mutated DNA. Researchers created patient-derived stem cells to study Pearson marrow pancreas syndrome, revealing insights into disease mechanisms.
Area of Science:
- Biochemistry
- Genetics
- Stem Cell Biology
Background:
- Congenital mitochondrial DNA (mtDNA) disorders are characterized by heteroplasmy, where varying levels of normal and mutated mtDNA influence disease severity and presentation.
- Pearson marrow pancreas syndrome (PS) is a congenital bone marrow failure disorder linked to heteroplasmic mtDNA deletions, but its underlying causes and suitable models remain unclear.
Observation:
- Induced pluripotent stem (iPS) cells retain cytoplasmic genetic material during reprogramming, making them ideal for studying mtDNA disorders.
- Researchers derived and characterized iPS cells from a PS patient, isolating isogenic lines with and without detectable deleted mtDNA by exploiting heteroplasmy changes during cell passage.
Findings:
- Differentiated PS-iPS cells with high levels of deleted mtDNA exhibited altered growth, mitochondrial function, and hematopoietic phenotypes compared to isogenic controls.
- This highlights the impact of heteroplasmy burden on cellular behavior and differentiation outcomes in PS.
Implications:
- Reprogramming somatic cells from patients with mtDNA disorders can generate pluripotent stem cells with diverse heteroplasmy levels.
- These iPS cell models offer a valuable platform for investigating mitochondrial diseases and exploring potential therapeutic strategies.
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Induced Pluripotent Stem Cells
Animal Mitochondrial Genetics
iPS Cell Differentiation

